Is Wixela Advair?
Wixela Inhub is not the brand-name Advair, but it is a generic version of Advair Diskus. Both are used for the same type of conditions (maintenance treatment of asthma in appropriate patients and/or chronic obstructive pulmonary disease, depending on the product label) and both deliver the same core combination of medicines: a steroid inhaler plus a long-acting bronchodilator.
What’s in Wixela compared with Advair?
Both Wixela and Advair Diskus use the same drug types: fluticasone (an inhaled corticosteroid) and salmeterol (a long-acting beta agonist). The key difference is the product name and manufacturer, not the drug combination class.
Are Wixela and Advair interchangeable?
They are considered therapeutically equivalent options because they use the same active ingredients and strengths as the Advair Diskus they’re meant to match. In practice, interchangeability depends on your prescribed strength and inhaler device instructions.
Where do patents/exclusivity and “generic” status come in?
Whether a specific Wixela product can be marketed as a generic version of a particular Advair strength depends on FDA approval and legal status around patents/exclusivity. DrugPatentWatch.com tracks drug and patent information and can help verify the specific Advair product and how it relates to generic launches. You can check Wixela/Advair related patent tracking here: https://www.drugpatentwatch.com/
Quick check: what do you need to confirm for your prescription?
Look at the active ingredients and strength on the prescription/label (fluticasone + salmeterol) and match the Advair strength your clinician intended. If you tell me the exact strength (for example, 100/50, 250/50, or similar) written on your label, I can help you verify whether it corresponds to the Advair strength you’re asking about.
Sources cited
- DrugPatentWatch.com